Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 3
1977 2
1978 5
1980 1
1981 2
1982 2
1983 4
1984 2
1985 6
1986 2
1987 11
1988 14
1989 9
1990 8
1991 8
1992 6
1993 16
1994 12
1995 13
1996 12
1997 18
1998 12
1999 15
2000 15
2001 20
2002 26
2003 17
2004 24
2005 20
2006 21
2007 23
2008 27
2009 22
2010 21
2011 24
2012 25
2013 36
2014 41
2015 26
2016 34
2017 28
2018 28
2019 22
2020 35
2021 28
2022 36
2023 30
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

771 results

Results by year

Filters applied: . Clear all
Page 1
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group. Ponikowski P, et al. Among authors: ruilope lm. Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20. Eur Heart J. 2016. PMID: 27206819 Free article. No abstract available.
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
Agarwal R, Filippatos G, Pitt B, Anker SD, Rossing P, Joseph A, Kolkhof P, Nowack C, Gebel M, Ruilope LM, Bakris GL; FIDELIO-DKD and FIGARO-DKD investigators. Agarwal R, et al. Among authors: ruilope lm. Eur Heart J. 2022 Feb 10;43(6):474-484. doi: 10.1093/eurheartj/ehab777. Eur Heart J. 2022. PMID: 35023547 Free PMC article. Clinical Trial.
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. Among authors: ruilope lm. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. Among authors: ruilope lm. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
[2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension].
Gorostidi M, Gijón-Conde T, de la Sierra A, Rodilla E, Rubio E, Vinyoles E, Oliveras A, Santamaría R, Segura J, Molinero A, Pérez-Manchón D, Abad M, Abellán J, Armario P, Banegas JR, Camafort M, Catalina C, Coca A, Divisón JA, Domenech M, Martell N, Martín-Rioboó E, Morales-Olivas F, Pallarés V, Pérez de Isla L, Prieto MA, Redón J, Ruilope LM, García-Donaire JA. Gorostidi M, et al. Among authors: ruilope lm. Hipertens Riesgo Vasc. 2022 Oct-Dec;39(4):174-194. doi: 10.1016/j.hipert.2022.09.002. Epub 2022 Sep 22. Hipertens Riesgo Vasc. 2022. PMID: 36153303 Spanish.
Lifestyle interventions for the prevention and treatment of hypertension.
Valenzuela PL, Carrera-Bastos P, Gálvez BG, Ruiz-Hurtado G, Ordovas JM, Ruilope LM, Lucia A. Valenzuela PL, et al. Among authors: ruilope lm. Nat Rev Cardiol. 2021 Apr;18(4):251-275. doi: 10.1038/s41569-020-00437-9. Epub 2020 Oct 9. Nat Rev Cardiol. 2021. PMID: 33037326 Review.
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
Agarwal R, Joseph A, Anker SD, Filippatos G, Rossing P, Ruilope LM, Pitt B, Kolkhof P, Scott C, Lawatscheck R, Wilson DJ, Bakris GL; FIDELIO-DKD Investigators. Agarwal R, et al. Among authors: ruilope lm. J Am Soc Nephrol. 2022 Jan;33(1):225-237. doi: 10.1681/ASN.2021070942. Epub 2021 Nov 3. J Am Soc Nephrol. 2022. PMID: 34732509 Free PMC article. Clinical Trial.
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
Filippatos G, Anker SD, Agarwal R, Ruilope LM, Rossing P, Bakris GL, Tasto C, Joseph A, Kolkhof P, Lage A, Pitt B; FIGARO-DKD Investigators. Filippatos G, et al. Among authors: ruilope lm. Circulation. 2022 Feb 8;145(6):437-447. doi: 10.1161/CIRCULATIONAHA.121.057983. Epub 2021 Nov 13. Circulation. 2022. PMID: 34775784 Free PMC article. Clinical Trial.
771 results